What Is Eylea HD, and Why Does It Matter? Eylea HD (aflibercept) is an injectable medicine used to treat certain eye conditions that can lead to vision loss. It works by blocking a protein called VEGF ...

Researchers have explored potential treatment that could bring unexpected relief to people living with severe vision loss.The ...

A new study demonstrates the effectiveness of a widely-used eye injection to manage the previously untreatable rare condition ...

Scientists at USC are launching a new trial to test a tiny stem cell implant that could restore vision in people with ...

An OU Health eye specialist explains who is most at risk, why symptoms are rare, and how early exams can prevent permanent blindness.

A Johnson & Johnson gene therapy in development for an inherited vision-loss disorder has failed a Phase 3 study, the latest clinical research setback for a rare eye disease that so far has no ...

A tiny chip the size of a grain of sand implanted in the back of the eye can effectively restore vision loss, scientists reveal. Measuring just 2mm x 2mm, the 'pioneering' implant is paired with a ...

Researchers estimate that about 1.8 billion people around the world live with presbyopia, a farsightedness condition that can appear as a person grows older. More recent treatment options for ...

Artificial intelligence is radically changing how healthcare providers tackle vision loss, with tools that can be used from diagnosis to treatment and even follow-up care. One such example is Visilant ...

The FDA has granted breakthrough therapy designation to privosegtor for optic neuritis, a common symptom of multiple ...

Glaucoma is a major public health issue in ophthalmology. Despite advances in diagnostics and treatment, it continues to be ...

Glaucoma is a blinding disease caused by damage to the optic nerve, leading to permanent vision loss. The main risk factor is ...